课题基金 / 基金详情

Risk of infections with tumour necrosis factor inhibitors (TNFi) in pregnant women and their offspring

Risk of infections with tumour necrosis factor inhibitors (TNFi) in pregnant women and their offspring
孕妇及其后代感染肿瘤坏死因子抑制剂（TNFi）的风险
批准号：
404923
负责人：
Vinet Evelyne
金额：
$7.65万
依托单位：
Research Institute of the McGill University Health Centre
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2019
资助国家：
加拿大
项目状态：
已结题
起止时间：
2019-05-01 至 2022-05-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=404923&lang=en
关键词：
Ankylosing Spondylitis Chronic Inflammatory Diseases Inflammatory Bowel Diseases Pregnancy Psoriasis Psoriatic Arthritis Rheumatoid Arthritis Rotavirus Vaccine Serious Infections Tumour Necrosis Factor Inhibitors

项目摘要

项目成果

Vinet Evelyne的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Tumour necrosis factor inhibitors (TNFi) are important drugs in the treatment of pregnant women with chronic inflammatory diseases. Despite existing concerns that these potent drugs may cause immunosuppression, there are limited data on the risk of infect
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Risk stratification and personalized therapy in lupus pregnancies
Risk of infections with tumour necrosis factor inhibitors (TNFi) in pregnant women and their offspring
The Lupus prEGnAnCY (LEGACY) Cohort
  • 批准号：
    364224
  • 项目类别：
    Operating Grants
  • 资助金额：
    $7.29万
  • 财政年份：
    2017
  • 负责人：
    Vinet Evelyne
  • 依托单位：
    McGill University Health Centre
Aspirin for prevention of adverse pregnancy outcomes in systemic lupus erythematosus
  • 批准号：
    334735
  • 项目类别：
    Miscellaneous Programs
  • 资助金额：
    $0.55万
  • 财政年份：
    2015
  • 负责人：
    Vinet Evelyne
  • 依托单位：
    McGill University Health Centre
海外基金